/

Nosis Bio

Developing AI-driven, receptor-targeted RNA therapeutics for chronic diseases.

BiotechnologyPharmaceuticals nosisbio.com ↗

Company facts

Founded: 2021
Employees: 15
Headquarters: United States
Type: Private
Funding: Seed · $2M · 2023